Literature DB >> 6093395

Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades.

A S Evans.   

Abstract

The hypothesis is presented that a human T-cell leukemia virus (HTLV) or a related agent produces a lytic response of T cells manifested by the acquired immune deficiency syndrome (AIDS) and a proliferative response represented by the adult leukemia/lymphoma (ATL) syndromes. The sequence or cascade of T-cell events following loss of T4 helper cells in AIDS includes reactivation of Epstein-Barr virus and a B-cell cascade of cytomegalovirus, resulting in Kaposi sarcoma in genetically susceptible persons, and of other intracellular agents (CNS viruses, M. avium intracellulari, T. gondii); opportunistic infections also occur. A comparison of AIDS and ATL syndromes is presented and the details of the B-cell cascade are outlined. The usefulness of prospective serological/immunological studies is discussed in an effort to determine the temporal sequence of infection by the candidate agents and their relation to the appearance of T4/T8 reversal and of the clinical features of AIDS.

Entities:  

Mesh:

Year:  1984        PMID: 6093395      PMCID: PMC2589847     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  45 in total

1.  Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.

Authors:  G Rocchi; G Tosato; G Papa; G Ragona
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

2.  Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; L Hutt; J Bhawan; J P Yang; C Cassel; S Allegra; F S Rosen
Journal:  Clin Immunol Immunopathol       Date:  1978-02

3.  Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma.

Authors:  J S Pagano; C H Huang; P Levine
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

4.  The spectrum of infections with Epstein-Barr virus: a hypothesis.

Authors:  A S Evans
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

5.  Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis.

Authors:  R N Sawyer; A S Evans; J C Niederman; R W McCollum
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

Review 6.  Heterophile antigens and antibodies in medicine.

Authors:  K Kano; F Milgrom
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

7.  Pathogenesis of infectious mononucleosis.

Authors:  M A Epstein; B G Achong
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

8.  Infectious mononucleosis: model for self-limiting lymphoproliferation.

Authors:  R L Carter
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

9.  Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.

Authors:  T J Hallee; A S Evans; J C Niederman; C M Brooks; j H Voegtly
Journal:  Yale J Biol Med       Date:  1974-09

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  3 in total

1.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

2.  Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.

Authors:  J C Lin; E De Clercq; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Authors:  M J Ohm-Smith; R L Sweet
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.